Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medicine /醫學院
  3. Institute of Medicine/醫學研究所
  4. 尋找參與Slit2剪接變異型所調控的血管新生訊號路徑
 
  • Details
Options

尋找參與Slit2剪接變異型所調控的血管新生訊號路徑

Date Issued
2015
Author(s)
王秀羽
Siou-Yu Wang
Advisor
蔡菁華
URI
https://handle.ncl.edu.tw/11296/mpwb23
https://scholars.csmu.edu.tw/handle/123456789/36159
Abstract
Slit2是一種分泌型醣蛋白,具有抑制腫瘤轉移的能力,它也可以抑制神經細胞以及內皮細胞(Endothelial Cells)的遷徙(migration)、影響發炎反應及腎臟與肺臟的發育。我們發現Slit2在Exon15擁有兩個剪接變異型(Alternative Splicing),分別為Slit2-WT和Slit2-ΔE15,Slit2-ΔE15具有抑制肺癌細胞的生長以及侵襲(invasion)的能力,但Slit2-WT只能抑制肺癌細胞的侵襲能力。過去的文獻指出Slit2與血管新生(angiogenesis)有關,所以我們利用人類臍帶靜脈內皮細胞(Human Umbilical Vein Endothelial Cells, HUVECs)來探討Slit2-WT與Slit2-ΔE15對於血管新生的影響。我們發現肺癌細胞的條件培養液會促進內皮細胞通透性(permeability)及形成不完整管束結構,Slit2-ΔE15可以抑制肺癌細胞所誘導的內皮細胞的通透性及恢復管束結構的完整性,但是Slit2-WT卻只能抑制HUVECs的通透性。在雞胚胎的尿囊膜(Chorioallantoic membrane)實驗中更進一步證實肺癌細胞的條件培養液會使得靠近表面的血管變細,而Slit2-ΔE15能夠使血管的大小正常化,但是Slit2-WT並沒有這樣的能力。因此,Slit2-ΔE15可以使HUVECs細胞的通透性降低並且使新生血管正常化,而Slit2-WT只具有降低HUVECs細胞通透性的能力。這些現象暗示著降低內皮細胞的通透性與新生血管正常化是透過不同的路徑所達成的。我們發現以si-RNA抑制Robo4的表現或anti-Robo4抑制Robo4的功能後,Slit2-WT及Slit2-ΔE15抑制癌細胞所誘導的高通透性的能力就消失了;而抑制Robo1的表現或功能後,Slit2-WT及Slit2-ΔE15仍能抑制癌細胞所誘導的高通透性,代表Slit2-WT及Slit2-ΔE15是透過Robo4去抑制癌細胞所誘導的高通透性。而出乎意料之外,無論是以si-RNA抑制HUVEC細胞上之Robo1或Robo4 的表現或是以抗體抑制Robo1或Robo4的功能之後,處理Slit2-ΔE15的條件培養液仍能形成完整的管束結構,這表示Slit2-ΔE15並不透過Robo1也不透過Robo4去影響HUVEC形成完整的管束結構。這些結果顯示,除了Robos受體之外,還有別的受體在Slit2-ΔE15所參與的血管新生上扮演著重要的角色。由於腫瘤周圍新生血管的正常化可以改善腫瘤微環境的充氧性、降低酸度及減少自由基的濃度,不僅可以降低腫瘤的惡化程度,更可以增進化療或放療的療效。因此,了解Slit2-ΔE15參與血管新生的受體將有助於發展引導腫瘤血管正常化的治療方針。
Slit2 is a secreted glycoprotein, which inhibits tumor metastasis, neuronal and endothelial cell migration, as well as affects inflammation and the development of kidneys and lungs. We identified two splicing forms of Slit2 at exon 15, exon 15-containing Slit2-WT and exon 15-deleted Slit2-ΔE15, respectively. Slit2-ΔE15 inhibits both growth and invasion of lung cancer cells, but Slit2-WT inhibits lung cancer cell invasion only. Previous studies have shown that Slit2 plays a role in angiogenesis, so we used human umbilical vein endothelial cells (HUVECs) to study the effect of Slit2 splicing variants on angiogenesis. We found that the conditioned medium (CM) of lung cancer cells increased permeability and formed poor tubes in HUVECs. The CM containing Slit2-ΔE15 inhibited CM-induced permeability of HUVECs and restored the quality of tubes, but Slit2-WT CM only inhibited CM-induced permeability of HUVECs. In chorioallantoic membrane (CAM) assay, the CM collected from lung cancer cells blocked angiogenesis on CAM, Slit2-ΔE15 CM restored the size of vessels, but Slit2-WT did not have this ability. Thus, our results indicated that Slit2-ΔE15 not only reduces cancer cell-induced permeability but also enhances the quality of vessels, while Slit2-WT inhibits cancer cell-induced permeability only. These results futher suggested that decreasing in permeability and enhancing vessel quality may be mediated by different pathways. When the expression level or the function of Robo4 was interfered by RNAi or anti-Robo4, respectively, Slit2-WT- or Slit2-ΔE15-mediated inhibition of CM-induced permeability was disappeared. But, knockdown Robo1 expression or function did not relieve Slit2-WT- or Slit2-ΔE15-mediated inhibition of permeability, indicating that Robo4 but not Robo1 is involved in Slit2-mediated inhibition of CM-induced permeability. Unexpectedly, knockdown the expression or function of either Robo1 or Robo4 did not block Slit2-ΔE15-enhanced tube quality. This result revealed the presence of unknown receptor(s) of Slit2-ΔE15 that transduce(s) the signal in the regulation of angiogenesis. Normalization of vessels will increase oxygen content, decrease acidity and reduce ROS in tumor microenvironment, which not only reduces malignancy of tumor but also enhances efficacy of chemotherapy or radiotherapy. Thus, identification of receptors involved in Slit2-ΔE15-mediated angiogenesis would provide the opportunity to develop strategy in normalizing blood vessel around tumor microenvironment.
Subjects
血管新生
剪接變異型
絨毛膜尿囊膜試驗
angiogenesis
CAM
Slit2
Type
thesis
File(s)
No Thumbnail Available
Name

103CSMU5534047-001.zip

Size

5.91 MB

Format

Unknown

Checksum

(MD5):c4b4bd4b16ce71637ba5f883551421cb

Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback